Tyrosine Kinase Inhibitors with or without Donor Lymphocyte Infusion Continue to Provide Long-Term Survival after Relapse of Chronic Myeloid Leukemia Following Hematopoietic Cell Transplantation

被引：1
|
作者：
Schmidt, Sarah Ann [1 ]
Chakrabarty, Jennifer Holter [2 ]
Liu, Ying [3 ,4 ]
Hu, Zhen-Huan [3 ]
Williams, Kirsten M. [5 ]
Alyea, Edwin P., III [6 ]
Popat, Uday [7 ]
Sobecks, Ronald [8 ]
Scott, Bart L.
Saber, Wael [3 ]
机构：
[1] Univ Oklahoma, Oklahoma City, OK USA
[2] Univ Oklahoma, Dept Hematol Oncol, Oklahoma City, OK USA
[3] Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53226 USA
[5] Childrens Natl Med Ctr, CETI, Washington, DC 20010 USA
[6] Dana Farber Canc Inst, Ctr Hematol Oncol, Boston, MA 02115 USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[8] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-118918
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
704
引用
收藏
页数：3
相关论文
共 50 条
  • [31] SURVIVAL AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR TYROSINE KINASE INHIBITORS (TKI) IN CHILDREN WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE; A SINGLE INSTITUTION EXPERIENCE
    Hijiya, Nobuko
    Broglie, Larisa
    Chaudhury, Sonali
    Rademaker, Alfred
    Helenowski, Irene
    Danner-Koptik, Karina
    Dilley, Kimberley
    Weinstein, Joanna
    Duerst, Reggie
    Kletzel, Morris
    Morgan, Elaine
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1049 - 1049
  • [32] Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
    Peng Zhao
    Ming Ni
    Dan Ma
    Qin Fang
    Yan Zhang
    Yanju Li
    Yi Huang
    Ying Chen
    Xiao Chai
    Yun Zhan
    Yan Li
    Qian Kang
    Mei Zhao
    Min Liu
    Fengqi Zhang
    Shisi Huang
    Shuangshuang Wen
    Bo Deng
    Jishi Wang
    Annals of Hematology, 2022, 101 : 119 - 130
  • [33] Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
    Sanna, Marco
    Caocci, Giovanni
    Vacca, Adriana
    Piras, Eugenia
    Orru, Federica
    La Nasa, Giorgio
    CASE REPORTS IN HEMATOLOGY, 2013, 2013
  • [34] Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
    Zhao, Peng
    Ni, Ming
    Ma, Dan
    Fang, Qin
    Zhang, Yan
    Li, Yanju
    Huang, Yi
    Chen, Ying
    Chai, Xiao
    Zhan, Yun
    Li, Yan
    Kang, Qian
    Zhao, Mei
    Liu, Min
    Zhang, Fengqi
    Huang, Shisi
    Wen, Shuangshuang
    Deng, Bo
    Wang, Jishi
    ANNALS OF HEMATOLOGY, 2022, 101 (01) : 119 - 130
  • [35] Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    Dazzi, F
    Szydlo, RM
    Cross, NCP
    Craddock, C
    Kaeda, J
    Kanfer, E
    Cwynarski, K
    Olavarria, E
    Yong, A
    Apperley, JF
    Goldman, JM
    BLOOD, 2000, 96 (08) : 2712 - 2716
  • [36] Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
    Kharfan-Dabaja, Mohamed A.
    Labopin, Myriam
    Polge, Emmanuelle
    Nishihori, Taiga
    Bazarbachi, Ali
    Finke, Juergen
    Stadler, Michael
    Ehninger, Gerhard
    Lioure, Bruno
    Schaap, Nicolaas
    Afanasyev, Boris
    Yeshurun, Moshe
    Isaksson, Cecilia
    Maertens, Johan
    Chalandon, Yves
    Schmid, Christoph
    Nagler, Arnon
    Mohty, Mohamad
    JAMA ONCOLOGY, 2018, 4 (09) : 1245 - 1253
  • [37] Factors affecting survival in acute leukemia with donor lymphocyte infusion in the first relapse after allogeneic stem cell transplantation
    Kurnaz, Fatih
    Sahin, Cem
    Kaynar, Leylagul
    Pala, Cigdem
    Sivgin, Serdar
    Altuntas, Fevzi
    Eser, Bulent
    Cetin, Mustafa
    Unal, Ali
    JOURNAL OF BUON, 2016, 21 (01): : 227 - 234
  • [38] Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors A case report
    Lee, Chang-Hoon
    Jeon, So Yeon
    Yhim, Ho-Young
    Jang, Kyu Yun
    Kwak, Jae-Yong
    MEDICINE, 2020, 99 (19) : E19962
  • [39] Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years
    Wada, Akinori
    Kobayashi, Naoki
    Asanuma, Shinsuke
    Matsuoka, Satomi
    Kosugi, Mizuha
    Fujii, Shiro
    Noguchi, Shinsuke
    Miyazono, Takayoshi
    Nakata, Masanobu
    Ota, Shuichi
    Imai, Kiyotoshi
    Hirano, Teiichi
    Ogasawara, Masahiro
    Kiyama, Yoshio
    Kasai, Masaharu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 118 - 122
  • [40] Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years
    Akinori Wada
    Naoki Kobayashi
    Shinsuke Asanuma
    Satomi Matsuoka
    Mizuha Kosugi
    Shiro Fujii
    Shinsuke Noguchi
    Takayoshi Miyazono
    Masanobu Nakata
    Shuichi Ota
    Kiyotoshi Imai
    Teiichi Hirano
    Masahiro Ogasawara
    Yoshio Kiyama
    Masaharu Kasai
    International Journal of Hematology, 2011, 93 : 118 - 122
12345